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The objective of this in vitro study was to explore the
applicability of Raman spectroscopy to distinguish
basal cell carcinoma from its surrounding non-
cancerous tissue; therefore, identifying possibilities
for the development of an in vivo diagnostic tech-
nique for tumor border demarcation. Raman spectra
were obtained in a two-dimensional grid from
unstained frozen sections of 15 basal cell carcinoma
specimens. Pseudo-color Raman images were gener-
ated by multivariate statistical analysis and clustering
analysis of spectra and compared with histopathol-
ogy. In this way a direct link between histologically
identi®able skin layers and structures and their
Raman spectra was made. A tissue classi®cation
model was developed, which discriminates between
basal cell carcinoma and surrounding nontumorous
tissue, based on Raman spectra. The logistic regres-
sion model, shows a 100% sensitivity and 93% select-
ivity for basal cell carcinoma. The Raman spectra
were, furthermore, used to obtain information about
the differences in molecular composition between
different skin layers and structures. An interesting
®nding was that in four samples of nodular basal cell
carcinoma, the collagen signal contribution in
spectra of dermis close to a basal cell carcinoma, was
markedly reduced. The study demonstrates the sensi-
tivity of Raman spectroscopy to biochemical changes
in tissue accompanying malignancy, resulting in a
high accuracy when discriminating between basal
cell carcinoma and noncancerous tissue. Key words:
dermis/nonmelanoma skin cancer/Raman microspectro-
scopy/skin. J Invest Dermatol 119:64±69, 2002
B
asal cell carcinoma (BCC) is the most common cancer
of the skin and its incidence is ever increasing
(Gallagher et al, 1990; Marks, 1995). The tumor most
often appears in the head and neck region, particularly
in Caucasians with a history of excessive sun exposure
(Kopf, 1979; Roenigk et al, 1986; Gallagher et al, 1995). Although
slowly growing and rarely metastatic, BCC can cause signi®cant
local destruction. Histopathologic examination is the gold standard
for con®rming the diagnosis. For most types of BCC, surgery is
recommended as ®rst-line treatment. A problem is presented by the
fact that the tumor borders cannot be detected visually with 100%
accuracy. This results in 5 y recurrence rates for primary BCC of
10.1% after simple surgical excision. Mohs' micrographic surgery is
a technique that can detect tumor margins with approximately
100% certainty: 5 y recurrence rates are only 1% for this surgical
approach (Rowe et al, 1989). Mohs' micrographic surgery,
however, is a time-consuming method, both for the pathologist
and the surgeon, which prevents its widespread use. Real-time
intraoperative in vivo determination of the tumor border would be a
solution to this problem.
In this in vitro study we have investigated whether this could in
principle be accomplished by means of Raman spectroscopy.
Raman spectroscopy is an optical method based on inelastic light
scattering. This technique provides detailed information concern-
ing the molecular composition of the tissue under study as well as
about molecular conformations and molecular interactions
(Koningstein, 1971). Disease leads to changes in the molecular
make-up of cells and tissues. The use of Raman spectroscopy for
the development of diagnostic methods is based on the fact that
these changes are re¯ected in the Raman spectrum. Depending on
the application one can either explicitly extract information
regarding molecular composition from the spectra, or one can
use the spectra as highly speci®c optical spectroscopic ®ngerprints,
by which tissues can be identi®ed. The technique is highly suitable
for in vivo application. It is nondestructive, it does not rely on the
use of dyes or labels and can be applied in vivo, e.g., through the use
of dedicated ®beroptic probes (reviewed in Puppels et al, 2001).
Raman spectroscopy is increasingly being used for skin research and
as the basis for the development of skin diagnostics. Insight in the
molecular composition of the skin was provided by in vitro as well as
in vivo Raman spectroscopy (Williams et al, 1994; Fendel, 1997;
Gniadecka et al, 1998; Caspers et al, 2001). This technique supplied
in vivo evidence for the accumulation of H2O2 and L-phenylalanine
in skin in vitiligo, supporting earlier observations concerning the
pathophysiologic mechanism of this disease (Schallreuter et al, 1998,
1999). Hata et al (2000) used the technique to determine the
carotenoid concentration in skin and reported evidence that this
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concentration correlates with the presence or absence of skin cancer
and precancerous lesions. In a number of in vitro studies spectral
differences have been reported between neoplastic tissue and
normal tissue of the brain, breast, colon, larynx, and cervix
(Mizuno et al, 1994; Frank et al, 1995; Manoharan et al, 1995;
Mahadevan-Jansen et al, 1998; Stone et al, 2000). For both colon
and breast tissue Raman spectroscopy was used to discriminate
between histologically normal tissue and cancerous tissue
(Manoharan et al, 1995; Frank et al, 1995). A study on the brain
showed differences in the Raman spectra obtained from various
kinds of tumors (Mizuno et al, 1994). The feasibility to use Raman
spectroscopy as a screening tool in the early detection of cervical
cancer was reported by Mahadevan-Jansen et al (1998). These
examples underline the fact that Raman spectra carry information
that enables discrimination between normal and (pre)cancerous
tissue.
More recently, ®beroptic probes have been used in in vivo studies
(Bakker Schut et al, 2000; Utzinger et al, 2001). The fact that tissue
classi®cation can be achieved instantaneously after collection of an
in vivo Raman spectrum (Bakker Schut et al, 2001), implies that the
road to the development of intraoperative applications of this
technique, for the purpose of assisting and guiding onco-surgical
procedures lies open. In particular, a procedure such as Mohs'
micrographic surgery would bene®t from such a method. With this
in mind we have studied the possibility of distinguishing BCC from
the surrounding noncancerous tissue.
The Raman study of Gniadecka et al (1997) on BCC was based
on measurements on whole biopsy specimens. No information on
local tissue composition is obtained in that way. As we wished to
address the question of whether it would be possible to determine
tumor margins by Raman spectroscopy, i.e., a question that
addresses tissue heterogeneity, we have chosen a different experi-
mental approach. By performing measurements on un®xed thin
tissue sections, speci®c spectral information on BCC, peritumoral
dermal connective tissue and epidermis was obtained. Based on this
information a prediction model for spectra obtained from BCC,
dermis, and epidermis was constructed.
MATERIALS AND METHODS
Ethical approval This protocol was approved by the Medical Ethics
Review Board of the University Hospital Rotterdam.
Sample preparation Excision specimens from 15 histologically proven
BCC (12 nodular and three super®cial), were obtained from 15
individuals from the outpatient clinic of the dermatology department of
the University Hospital Rotterdam, after informed consent. A biopsy was
taken from each sample, snap-frozen in liquid nitrogen and stored at ±
80°C until use. Cryosections (25 mm thickness) were obtained from the
biopsy specimens and placed on CaF2 slides for Raman spectroscopy. At
the time of spectroscopic investigation, the BCC sections were thawed
to reach room temperature and allowed to dry in air. Areas of interest
for Raman measurements (containing BCC, dermis, and/or epidermis)
on unstained sections were identi®ed on adjacent sections that were
®xed in formalin and stained in hematoxylin and eosin (H&E).
Reference spectra Reference spectra were obtained from calf thymus
DNA, collagen type I, human placenta, and oleic acid. These
compounds were purchased from Sigma-Aldrich (Sigma-Aldrich chemie,
Zwijndrecht, the Netherlands) and ICN Biochemicals (Aurora, OH) and
were used without further puri®cation. Calf thymus DNA was dissolved
in demineralized water (20 mg per ml).
Raman instrumentation To collect Raman spectra, near infrared
laser light (» 850 nm) from an argon-ion pumped titanium±sapphire laser
system (Spectra Physics, Mountain View, CA) was coupled with a
microscope (DM-RXE, Leica, Cambridge, U.K.) via a single mode
optical ®ber and a high pass ®lter as described and illustrated earlier (Van
de Poll et al, 2001). A near infrared optimized objective (3 80 MIR-
plan Olympus, Japan) with a working distance of approximately 1.6 mm
was used to focus the laser light on to the tissue sample, and to collect
light scattered by the sample. A chevron-type dielectric ®lter set (high
pass ®lter) was used for optical coupling of the laser, the microscope and
the spectrometer, and for suppression of the laser light that was scattered
back by the tissue sample (Puppels et al, 1994). The inelastically scattered
Raman light was focused on to the 100 mm diameter core of an optical
®ber, which guided the light into a spectrometer (System 100,
Renishaw, Wotton under Edge, U.K.), equipped with a
thermoelectrically cooled deep-depletion charge coupled device camera.
The charge coupled device camera was connected to a personal
computer where data were stored and analyzed. The microscope was
equipped with a motorized, computer-controlled sample stage, which
enabled automatic scanning of the sample. The area to be scanned and
the scanning step size were programmable. Acquisition of Raman spectra
and microscopic stage movement were controlled by Grams/32 Spectral
Notebase Software (Galactic Industries, Salem, NH). Spectral resolution
of the system was approximately 8 cm±1.
Raman data For each sample, an area on the cryosection was selected
for Raman measurements, containing BCC, dermis, and/or epidermis.
This area was scanned in two dimensions using a step size of 10 mm.
Laser light of 100 mW was focused on the tissue section to a spot of
about 1 mm in diameter. The signal collection time for each pixel was
10 s, during which time the pixel area (of 10 3 10 mm2) was scanned
through the laser focus so as to obtain a pixel-averaged Raman spectrum.
The selected area varied from 0.05 mm2 (500 spectra) to 0.4 mm2 (4000
spectra), depending on the size of the biopsy.
Data analysis
Wave number calibration and sensitivity correction Wave number calibration,
subtraction of the background signal, cosmic ray removal, and intensity
correction for the wave number dependent signal detection ef®ciency of
the setup were performed as described previously (Wolthuis et al, 1999).
Construction of Raman pseudo-color image In order to construct a pseudo-
color image, spectra obtained from each sample were analyzed separately.
Principal components analysis was performed on the Raman spectra, to
orthogonalize and reduce the number of parameters needed to represent
the variance in the spectral data set (Jollife, 1986). The ®rst 100 principal
components were calculated, typically accounting for more than 95% to
up to 99% of the variation in the data set. The principal components
scores, obtained for each spectrum, were used as input for K-means
clustering analysis (KCA). This clustering analysis algorithm was used to
®nd groups of spectra with similar spectral characteristics (clusters). KCA
was used, as this clustering method can easily handle large amounts of
data like the Raman maps presented here (Jain and Dubes, 1988). In
short KCA works as follows. First, the number of clusters in which the
spectra are grouped by KCA, is de®ned by the user. For each of these
clusters a spectrum is randomly chosen from the spectra in the data set,
to act as the initial cluster center. All spectra in the data set are then
compared with these cluster centers and assigned to the center that they
most resemble. After all spectra are assigned to a certain cluster, new
cluster centers are calculated by averaging all spectra assigned to that
cluster. This procedure is repeated until a stable solution is reached. In
this study, KCA was repeated with an increasing number of clusters, as
long as the ®nal cluster means showed differences clearly above noise
level and the clusters contained more than 10 spectra. In this way, the
optimal number of clusters can be determined that account for the
variance in the tissue Raman spectra at the spatial resolution used in the
Raman experiments. After KCA, a different color was assigned to each
cluster. Each grid element of the Raman map was then assigned the
color of the particular cluster to which its spectrum belonged. In this
way a pseudo-color-image of the frozen section was created, in which
areas with similar spectra had the same color. This pseudo-color image
was then compared with the H&E-stained tissue section.
Development of a classi®cation model The results of the KCA were further
used for creating a database of spectra of healthy tissue and BCC. The
spectra that constituted a cluster were averaged and this cluster mean was
entered into the database. This was repeated for each sample. Any
spectrum belonging to a cluster that was more than three times the
standard deviation from the mean of the cluster was omitted, in order to
eliminate spectral outliers. The H&E-stained adjacent tissue section was
used for histopathologic classi®cation of the tissue areas corresponding to
cluster means in the Raman pseudo-color-map. In this way, all cluster
means for each map were calculated and assigned to the following three
classes: BCC, dermis, and epidermis.
This data set of cluster means and the histopathologic classi®cation of
these cluster means were used to create a multivariate statistical classi®ca-
tion model. Again principal components analysis was used to orthogona-
lize and reduce the number of parameters needed to represent the
variance in the spectral data set. The scores on the ®rst two principal
components, representing the most signi®cant signal variance, were used
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as input for the classi®cation model together with the histopathologic
classi®cation. The prediction algorithm was based on the method of
logistic regression. Logistic regression is a variation of ordinary regression,
useful when the observed outcome is restricted to two values, usually
representing the occurrence or nonoccurrence of some outcome event
(Tabachnick and Fidell, 1996). As explained in the Results section the
prediction algorithm consisted of two consecutive steps. In the ®rst step
dermis was distinguished from BCC and epidermis. In the second step
BCC and epidermis were separated from each other (Fig 1). The
sensitivity and speci®city of the classi®cation model were estimated by a
leave-one-out cross-validation (Stone, 1974). The spectra of all but one
cluster mean were used to generate both the logistic regression-classi®ca-
tion models. The cluster mean that was left out was used to test the
accuracy of the identi®cation models. By repeating this procedure, and
leaving each cluster mean out in turn, information was obtained on the
reproducibility of the identi®cation procedure.
RESULTS
Raman pseudo-color maps In all 15 samples, obtained from
15 different patients, the pseudo-color Raman map and the
microscopic image of the H&E stained sample were found to
correlate very well. An example is shown in Fig 2. Figure 2(a)
shows a pseudo-color Raman map of a BCC and the surrounding
dermis, the area that was scanned measured 410 3 180 mm. The
Raman map, which is the result of a KCA of the 3108 Raman
spectra (see Materials and Methods) closely corresponds to the
microscopic image of the H&E stained adjacent section (Fig 2b). It
shows that the black area in the Raman map corresponds to tumor
tissue; the white area corresponds to the surrounding tissue. The
cluster averages of Raman spectra, collected from the scanned area
are shown in Fig 2(c). There is a marked difference between the
Raman spectra of BCC (spectrum 1) and surrounding tumor-free
dermis (spectrum 2). The characteristic spectral features of BCC
were enhanced by calculating a difference spectrum BCC minus
dermis (spectrum 3 of Fig 2c), which shows a high amount of lipids
and nucleic acids (Fig 2c). Table I represents the speci®c band
assignments of the Raman peaks in the difference spectrum (Erfurth
and Peticolas, 1975; Thomas and Prescott, 1977; Tu, 1982;
Prescott et al, 1984; Ong et al, 1999). The bands at 856 cm±1 and
936 cm±1 in the spectrum of the collagen-rich tumor-free dermis,
are a typical feature of collagen spectra and are due to proline and
protein backbone vibrations (C±C stretching) (Frushour and
Koenig, 1975).
In all Raman maps BCC was clearly separated from its
surrounding nontumorous tissue by the KCA. This was not the
only distinction noticed. In a number of cases KCA resulted in
several clusters of Raman spectra, within the tissue surrounding the
tumor, re¯ecting regional variance in biochemical composition. In
four Raman maps of nodular BCC, KCA formed separate clusters
for dermis in the vicinity of the tumor (» 50±150 mm) and dermis
further away from the tumor (Fig 3a). The microscopic image
shows a collagen-poor dermis immediately adjacent to the tumor
(Fig 3b). The remaining Raman maps (11) did not show a similar
distinction. In three of the 15 frozen sections a dense in¯ammatory
in®ltrate was present in the area of interest, resulting in a separate
cluster of Raman spectra (Figs 3c,d). As Raman spectra are a direct
re¯ection of the molecular composition of the tissue, a comparison
Figure 2. Comparison of microscopic image
of BCC and pseudo-color Raman map with
corresponding Raman spectra. Pseudo-color
Raman map, based on Raman spectra obtained
from a frozen tissue section of BCC. A Raman
spectrum was obtained for each 10 3 10 mm2
pixel. KCA yielded two clusters corresponding to
BCC and surrounding dermis as follows from a
comparison with (b). H&E-stained thin section
adjacent to the section used in the Raman
experiment, showing nodular BCC (b1) and its
surrounding tumor-free dermis (b2). The area
shown corresponds to the area scanned in the
Raman experiment. Cluster averaged Raman
spectra from BCC (c1) and dermis (c2). To
enhance the characteristic spectral features of BCC
a difference spectrum BCC dermis (c3) was
calculated. The dashed lines indicate bands in the
difference spectrum that can be attributed to
fatty acid represented here by oleic acid (c4) and
DNA (c5).
Figure 1. Two-step classi®cation model using logistic regression.
The database of Raman spectra obtained from BCC, dermis, and
epidermis was used as input for the classi®cation model. The ®rst logistic
regression model distinguishes dermis from BCC and epidermis. The
second model separates epidermis and BCC.
Table I. Observed wave numbers of Raman peaks of
difference spectrum BCC dermis and their assignments,
characteristic for BCC
Wave number
(cm±1) Assignment
727 Adenine
746 Thymine
786 DNA, RNA (PO2 symmetric stretching)
830 DNA (PO2 asymmetric stretching), tyrosine
900 Unassigned
957 Lipids, proteins (CH3 deformations)
1003 Phenylalanine (ring breathing)
1085 Lipids, nucleic acids backbone (PO2 symmetric stretching)
1127 Lipids (C±C stretching, trans)
1207 Tyrosine, phenylalanine
1304 Lipids; proteins (amide III band), adenine, cytosine
1336 Adenine, phenylalanine, CH deformations
1445 Lipids, proteins (CH2 deformation)
1651 Lipids C=C stretching
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of the spectral cluster means provides information about the
differences in molecular composition in the tissue. Clear differences
between spectra derived from BCC and spectra derived from
tumor-free dermis were found in all cases. The signal obtained from
the dermis, located between 800 and 990 cm±1, 1010 and
1100 cm±1, and 1220 and 1300 cm±1, as well as the bands at
1450 cm±1 and 1665 cm±1 is to a large extent due to collagen
(Fig 4). Figure 4 shows spectra obtained from a sample in which
Raman mapping resulted in separate clusters for dermis at a greater
distance from the tumor (Fig 4a), and dermis in the vicinity of the
tumor (Fig 4b). To clarify the difference between the two spectra a
difference spectrum (Fig 4d) was calculated and compared with the
spectrum obtained from pure collagen type I (Fig 4f). This shows
that the dermis in the vicinity of the tumor contains less collagen
than dermis at a greater distance from the tumor. The Raman
spectrum obtained from dermis containing a dense chronic
in¯ammatory in®ltrate (Fig 4c) also had a diminished but still
signi®cant collagen contribution, as can be deduced from the
difference spectrum dermis minus in®ltrate (Fig 4e). The difference
spectrum of dermis with a dense chronic in¯ammatory in®ltrate
minus dermis (Fig 4g) has a number of features in common with a
typical fatty acid spectrum (Fig 4h), indicated by dashed lines.
Other bands in the difference spectrum may be attributable to
tyrosine (830 cm±1) and phenylalanine (1003 cm±1).
Whereas the distinction between Raman spectra obtained from
BCC and dermis was apparent, differences in Raman spectra
derived from BCC and epidermis were more subtle (Fig 5). To
enhance the small spectral differences between the two spectra, a
difference spectra BCC minus epidermis was calculated (Fig 5c). A
comparison with a Raman spectrum of pure DNA (Fig 5d) shows,
that part of the spectral features in the difference spectrum are due
to a relatively higher DNA content of BCC.
Classi®cation of Raman spectra The cluster analysis of all 15
Raman maps resulted in 59 clusters, from which 59 cluster means
were calculated. By comparing the pseudo-color Raman maps with
the images of the H&E-stained tissue section all clusters could be
assigned to a particular skin layer. The clusters (three)
corresponding to dermis with an in¯ammatory in®ltrate were
assigned to the dermis. This classi®cation resulted in 31 dermis
spectra, 10 epidermis spectra, and 18 BCC spectra. The 59 cluster
means from the 15 Raman images were used to create a tissue
classi®cation model, to discriminate BCC from its surrounding
nontumorous tissue. This classi®cation model was based on logistic
regression (see Materials and Methods) and consisted of two
consecutive steps (Fig 1). The dermal spectra shown in
Fig 4(a,b) clearly differ from the Raman spectra obtained from
BCC or epidermis shown in Fig 5(a,b). Therefore, in the ®rst step
dermis was distinguished from the BCC and epidermis. Because of
the much closer similarity of their spectra BCC and epidermis were
separated from each other in the second step of the classi®cation
model.
The performance of this model was tested by means of a leave-
one-out cross-validation, in which 58 spectra were used to create a
classi®cation model. The model was then used to predict the tissue
type from which the 59th spectrum was obtained. This procedure
was repeated for all 59 spectra and the results are shown in
Table II. All spectra derived from BCC and dermis were correctly
predicted by this model. Three of the epidermal spectra were
Figure 3. Comparison of pseudo-color
Raman maps with images of H&E-stained
adjacent sections. (a,b) BCC and surrounding
dermis: Clustering analysis of the Raman spectra
distinguishes BCC, dermis directly surrounding
the tumor and dermis at a greater distance from
the tumor. (c,d) KCA again distinguishes BCC,
dermis directly surrounding the tumor and dermis
at a greater distance from the tumor. Furthermore,
a dense in¯ammatory in®ltrate is present and
detected by Raman spectroscopy. Black = BCC;
red = dermis close to tumor; green = dermis at a
greater distance from tumor; blue = dense chronic
in¯ammatory in®ltrate. 1 = BCC; 2 = collagen-
poor dermis; 3 = collagen-rich dermis; 4 =
chronic in¯ammatory in®ltrate. Scale bar: 100 mm.
Figure 4. Raman spectra of the dermis adjacent to BCC. (a)
Raman spectrum from dermis at a greater distance from the tumor;
green area in Fig 3(a). (b) Raman spectrum obtained from dermis
directly surrounding the tumor; red area in Fig 3(a). (c) Raman
spectrum obtained from dermis with a dense chronic in¯ammatory
in®ltrate; blue area in Fig 3(c). (d) Difference spectrum a±b. (e)
Difference spectrum a±c. (f) Raman spectrum of pure collagen type 1. (g)
Difference spectrum c±a. (h) Raman spectrum of oleic acid. Note the
strong resemblance between the spectra d, e, and f as well as g and h. For
clarity of presentation the difference spectra were magni®ed by a
factor 1.5.
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misclassi®ed and predicted as BCC. This results in a sensitivity and
speci®city for BCC of 100% and 93%, respectively.
DISCUSSION
This in vitro study demonstrates that Raman spectroscopy is an
adequate technique to distinguish BCC from nontumorous
surrounding tissue. By comparing Raman maps to the adjacent
H&E-stained sections, a direct correlation between spectra and
histology could be made. Besides BCC, dermis, and epidermis,
different histopathologic areas within the dermis, such as dense
in¯ammation, could also be detected. In four maps the dermis
directly surrounding the tumor was separated from dermis at a
greater distance from the tumor by the cluster analysis, which is
indicative for the sensitivity of Raman spectroscopy.
Qualitative analysis of dermal spectra showed a strong resem-
blance to collagen spectra. This is not surprising as collagen
accounts for at least 70% of the dry weight of the dermis (Jakubovic
and Ackerman, 1992). In the four pseudo-color-maps, mentioned
above the dermal spectra were separated into two groups. It appears
that the extracellular matrix surrounding the tumor is changed in
these samples. The Raman spectra obtained from the dermis
directly surrounding the tumor indicate a lower collagen content in
this area. This is consistent with the theory, that matrix
metalloproteinases play a pathogenetic role in BCC, degrading
the extracellular matrix components (Kahari and Saarialho-Kere,
1997; Tsukifuji et al, 1997; Varani et al, 2000). Furthermore, we
have analyzed the spectral differences between dermis with and
without a dense chronic in¯ammatory in®ltrate. Difference spectra
clearly show differences in overall molecular composition; dermis
with a dense in¯ammatory in®ltrate showing a higher amount of
fatty acids and aromatic amino acids and less collagen than dermis
without a dense in¯ammatory in®ltrate. It is tempting to attribute
the spectral bands in the low wave number area (500±650 cm±1) to
a decrease of disul®de bonds due to the oxidation of proteins (Tu,
1982). This requires further investigation, however, as the observed
difference features may equally well be linked to the differences in
overall molecular composition.
A comparison of the Raman spectra (Fig 2C) showed that BCC
contains a higher a higher amount of lipids and nucleic acids than
the surrounding dermis. Accumulation of lipids in tumor cells was
described earlier in tumor cells of glioblastoma and in conditionally
transformed tumor cells (Hirakawa et al, 1991; Barba et al, 1999).
The higher amount of nucleic acids re¯ects the higher cell density
of the tumor compared with the dermis. Raman spectra of BCC
and epidermis were quite similar; probably a re¯ection of the fact
that both consist predominantly of epithelial cells. The subtle
difference between Raman spectra obtained from BCC and
epidermis is in part due to a greater DNA content per mm2 in
examples of BCC, re¯ecting the higher cell density, apparent in the
microscopic images of BCC.
The good correlation between histology and the pseudo-color
maps based on clustering analysis of Raman spectra already
illustrated the ability of Raman spectroscopy to distinguish BCC
from its surrounding tissue in individual tissue sections. The results
of a tissue classi®cation model based on logistic regression of a
database of Raman spectra of BCC, and surrounding dermis and
epidermis show that a prediction model can also be constructed that
accurately classi®es new tissue samples on the basis of their Raman
spectrum. This model was able to detect BCC with a high
sensitivity and speci®city of 100% and 93%, respectively. At the ®rst
level of the hierarchical classi®cation model dermis could be
separated from BCC and epidermis, with 100% accuracy.
Discriminating BCC from epidermis, at the second level, was
more dif®cult because the Raman spectra were quite similar. This
resulted in misclassi®cation of three epidermal spectra, which were
predicted as BCC.
The prediction model was constructed, using only the ®rst two
principal components that were calculated by a principal
components analysis of the database. This ful®lls the ``rule of
thumb'' condition that the number of principal components used as
input for the classi®cation model should be at least two times
smaller than the smallest model group, in order to prevent
over®tting of the data set. As the ®rst principal components re¯ect
the largest signal variance in the database, this implies that the signal
variance that corresponds to the difference between healthy tissue
and BCC is also the most signi®cant signal variance encountered in
the skin samples. In so doing, a very robust classi®cation model was
constructed. Gniadecka et al (1997) reported signi®cant spectral
differences between BCC and normal skin, measuring whole
biopsy specimens; however, no spatial information could be
obtained in that way and consequently whole biopsy spectra
contain signal contributions from different skin layers and/or
structures.
We plan to use the speci®c spectral information obtained in this
study for the development of an in vivo technique for tumor border
demarcation of BCC. Raman spectroscopy is highly suitable for
in vivo application, as it is noninvasive and can be applied through
the use of hand-held ®beroptic probes at virtually any location on
or in the body (Puppels et al, 2001). Recently, Bakker Schut et al
Figure 5. Comparison of pure DNA to a difference spectrum of
BCC and epidermis. (a) Raman spectrum of BCC. (b) Raman
spectrum of epidermis. (c)To enhance the differences between the two
spectra (a,b), a difference spectra (a,b) were calculated. For clarity of
presentation the difference spectrum was magni®ed by a factor 2.0. (d)
DNA±Raman spectrum. Prominent and characteristic DNA±Raman
bands are present in the difference spectrum BCC±DNA (c).
Table II. Performance of the Raman-based tissue
classi®cation model
Pathology
BCC Dermis Epidermis Total
Raman
BCC 18 0 3 21
Dermis 0 31 0 31
Epidermis 0 0 7 7
Total 18 31 10 59
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(2000) reported a sensitivity of 100% and a speci®city of 100%,
distinguishing between normal tissue and high-grade dysplasia in rat
palate tissue in signal collection times of 10 s in vivo using a
®beroptic probe. In principle, tissue classi®cation can be achieved
instantaneously after collection of a spectrum (Bakker Schut et al,
2001). This implies that the road to development of intraoperative
applications of this technique for the purpose of assisting and
guiding onco-surgical procedures lies open. In the future it may
become a good alternative to the time-consuming Mohs'
micrographic surgery.
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